Clinical Trial Update: Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated cytarabine and daunorubicin with or without gemtuzumab ozogamicin in older patients with acute myeloid leukemia or myelodysplastic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Gemtuzumab ozogamicin (gemtuzumab ozogamicin)

Snippet

Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 3 | Status: COMPLETED